The Netherlands-based biomaterials start-up intends to expand its platform's reach through strategic partnerships and tuck-in acquisitions.

Each month, Start-Up presents a comprehensive review of young, private life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

Drug Discovery Tools; Genomics. Sequenom combines mass spectrometry, DNA conditioning chemistry, and a patented DNA chip to identify and analyze high volumes of DNA with great accuracy. The technology measures the molecular weight of DNA samples to reveal disease-causing molecules.